NTRA

Natera Inc

NTRA, USA

Natera, Inc., a diagnostics company, provides molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera molecular residual disease test for assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based genomic profiling test, that provides insight into genomic alterations and biomarkers; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product. It serves independent laboratories, national and regional reference laboratories, medical centers and physician practices, research laboratories, and pharmaceutical companies through its direct sales force, and a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.

https://www.natera.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
NTRA
stock
NTRA

What's Driving the Market Sentiment Around Natera Inc? Benzinga

Read more →
NTRA
stock
NTRA

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Makes New $1.24 Million Investment in Natera, Inc. $NTRA MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$234.6842

Analyst Picks

Strong Buy

12

Buy

8

Hold

0

Sell

1

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

25.29

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-6.99 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-4.81 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

4.13 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

High

0.45

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 84.92% of the total shares of Natera Inc

1.

Vanguard Group Inc

(9.2363%)

since

2025/06/30

2.

T. Rowe Price Associates, Inc.

(8.8801%)

since

2025/06/30

3.

BlackRock Inc

(7.9831%)

since

2025/06/30

4.

JPMorgan Chase & Co

(7.742%)

since

2025/06/30

5.

Farallon Capital Management, L.L.C.

(3.5132%)

since

2025/06/30

6.

Vanguard Total Stock Mkt Idx Inv

(2.9777%)

since

2025/07/31

7.

JPMorgan Large Cap Growth I

(2.8607%)

since

2025/07/31

8.

State Street Corp

(2.4172%)

since

2025/06/30

9.

Vanguard Small Cap Index

(2.2949%)

since

2025/07/31

10.

Duquesne Family Office LLC

(2.2479%)

since

2025/06/30

11.

Wellington Management Company LLP

(1.9189%)

since

2025/06/30

12.

RTW INVESTMENTS, LLC

(1.8897%)

since

2025/06/30

13.

Geode Capital Management, LLC

(1.8599%)

since

2025/06/30

14.

Fred Alger Management, LLC

(1.7563%)

since

2025/06/30

15.

Massachusetts Financial Services Company

(1.4897%)

since

2025/06/30

16.

Franklin Resources Inc

(1.4118%)

since

2025/06/30

17.

Amvescap Plc.

(1.363%)

since

2025/06/30

18.

Vanguard Small Cap Growth Index Inv

(1.2922%)

since

2025/07/31

19.

AQR Capital Management LLC

(1.2581%)

since

2025/06/30

20.

Castle Hook Partners LP

(1.2201%)

since

2025/06/30

21.

NORGES BANK

(1.1979%)

since

2025/06/30

22.

Franklin Innovation Composite

(1.1556%)

since

2025/06/30

23.

US Small-Cap Growth II Equity Comp

(1.1448%)

since

2025/06/30

24.

Sofinnova Ventures

(1.1295%)

since

2025/06/30

25.

T. Rowe Price New Horizons

(1.0939%)

since

2025/07/31

26.

Franklin DynaTech A

(1.0929%)

since

2025/07/31

27.

Maverick Capital Ltd

(1.0854%)

since

2025/06/30

28.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0697%)

since

2025/07/31

29.

Goldman Sachs Group Inc

(1.0682%)

since

2025/06/30

30.

MFS Mid Cap Growth Equity

(1.0527%)

since

2025/06/30

31.

MFS Mid Cap Growth A

(1.0252%)

since

2025/07/31

32.

T. Rowe Price US Growth Stock Composite

(0.9513%)

since

2025/06/30

33.

JPMorgan Growth Advantage A

(0.9268%)

since

2025/07/31

34.

T. Rowe Price Growth Stock

(0.8874%)

since

2025/07/31

35.

T. Rowe Price Lrg Cp Gr I

(0.8106%)

since

2025/07/31

36.

JPM US Mid Cap Growth-Composite

(0.7526%)

since

2025/06/30

37.

T. Rowe Price Growth Stock Tr-B

(0.7246%)

since

2025/06/30

38.

American Funds Growth Fund of Amer A

(0.7204%)

since

2025/06/30

39.

Capital Group Growth Fnd of Amer Comp

(0.7204%)

since

2025/06/30

40.

JPMorgan Mid Cap Growth I

(0.6954%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.3571

Latest Release

Date

2025-09-30

EPS Actual

-0.64

EPS Estimate

-0.37

EPS Difference

-0.27

Surprise Percent

-72.973%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.8)
GARP
Fair GARP(4.5)
Growth
Weak Growth Prospect(3)
Momentum
Moderate Momentum(4)
Net Net
Possible Net-Net(4)
Quality
Moderate Quality(4.5)
Value
Fair Value(3.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.